UK charity donates generous funding for eye disease treatment

Article

Fight for Sight has donated £1.6 million towards ten research grants focused on tackling sight loss and eye disease treatment.

Fight for Sight has donated £1.6 million towards ten research grants focused on tackling sight loss and eye disease treatment.

The research grants will be given to a clinical fellowship, two early career investigator awards and seven project grants. Work will begin universities and hospitals across the UK and aims to develop treatment for age-related macular degeneration, glaucoma, eyelid cancer, inherited paediatric retinal disease and diabetic retinopathy.

Dr Dolores Conroy, Director of Research at Fight for Sight, commented, "Currently, there are a huge number of eye conditions that we do not know enough about, and which have few treatment options – such as age-related macular degeneration and diabetic retinopathy. It is therefore crucial that we invest as much as we can into research, which could bring us closer to finding new ways to help people living with sight loss. We hope our commitment to funding pioneering research will bring us even closer to a future everyone can see.”

To find out more about the charity please click here

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.